News about genomics analysis tools including next generation sequencing, electrophoresis, PCR, and others
Canopy Biosciences signs agreement with Cosmo Bio to sell gene engineering products in Japan ST. LOUIS, June 22, 2017 /PRNewswire/ — Canopy BiosciencesTM, LLC (“Canopy Biosciences”), an emerging provider of gene editing and personalized medicine technologies, announced a distributor agreement with Cosmo Bio Co., Ltd. (“Cosmo Bio“) for its TUNR Flexible Gene Editing technology in Japan. ... Read more
Commercial agreement with Congenica supports UniteGen’s goal of achieving the world’s largest human genome database Cambridge, UK – 21st June – Congenica’s Sapientia™ clinical genome analysis software platform will be used by China-based UniteGen to carry out whole genome sequencing (WGS) processing and analysis as part of China’s “100K Wellness Pioneer Project”, hosted by Beijing... Read more
SAN FRANCISCO, June 15, 2017 /PRNewswire/ — Twist Bioscience, a company accelerating science and innovation through rapid, high-quality DNA synthesis, and the BioBricks Foundation today announced a groundbreaking agreement to provide 10,000 genes to the synthetic biology community. Under the terms of the agreement, the BioBricks Foundation (BBF) will pay for synthesis of 10,000 genes from... Read more
Enabling Product for Automated, Large Volume cell free DNA (cfDNA) Isolation The Magnum FLX24 Universal 24-well Magnet Plate provides unprecedented flexibility for large volume, magnetic bead-based extractions of nucleic acids or proteins with the quality and speed you have come to expect from Alpaqua magnet plates. The Magnum … BEVERLY, Mass., June 15, 2017 /PRNewswire/... Read more
JUN 14, 2017 — Aggregate New Funding in 2017 Reaches $60 Million; Total of $191 Million Raised Since Inception – — Accelerates Growth into Drug Discovery, Supports Investment in DNA Data Storage – SAN FRANCISCO, Calif. – June 14, 2017 – Twist Bioscience Corporation, a company accelerating science and innovation through rapid, high-quality DNA synthesis,... Read more
Wednesday, June 14, 2017 MENLO PARK, Calif., June 14, 2017 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ:PACB) today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. Pacific Biosciences also intends to grant the underwriters a 30-day option to purchase up to an additional... Read more
News Release June 14, 2017 Your Contact: Karen Tiano +1 978-495-0093 MilliporeSigma Awarded its First CRISPR Patent by Australian Patent Office Patent covers successful integration of an external DNA sequence into the chromosome of eukaryotic cells using CRISPR Similar patents pending in other countries; anticipate favorable outcomes Billerica, Massachusetts, June 14, 2017 — MilliporeSigma today announced... Read more
OMAHA, Neb. (June 13, 2017) — Transgenomic, Inc. (OTCQB: TBIO) today reported that the European Patent Office (EPO) has confirmed its intention to grant a patent covering multiplexed ICE COLD-PCR (MX-ICP) technology in the European Union (EU). This Dana-Farber Cancer Institute patent is exclusively licensed to Transgenomic. Paul Kinnon, President and CEO of Transgenomic, commented,... Read more
NEW YORK and HILDEN, Germany, (June 3, 2017) – Bristol-Myers Squibb Company (NYSE: BMY) and QIAGEN(NASDAQ: QGEN; Frankfurt Prime Standard: QIA) have signed an agreement to explore the use of next-generation sequencing (NGS) technology to develop gene expression profiles (GEPs) as predictive or prognostic tools for use with Bristol-Myers Squibb novel immuno-oncology (I-O) therapies in... Read more
Option to add new biomarkers for microsatellite instability (MSI) and mismatch repair (MMR) to QIAGEN’ s NGS panels Hilden, Germany, and Germantown, Maryland, June 3, 2017 – QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it has received a worldwide license from The Johns Hopkins University for biomarkers that have been shown to play... Read more